Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway

References

• Bray F , Ferlay J , Soerjomataram I , Siegel RL , Torre LA , Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2018;68:394–424. doi:10.3322/caac.21492 30207593
   PubMed Web of Science ®Google Scholar
• Liang H , Fan JH , Qiao YL . Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med . 2017;14:33–41. doi:10.20892/j.issn.2095-3941.2016.0093 28443201
   PubMed Web of Science ®Google Scholar
• Zhang Y . Epidemiology of esophageal cancer. World J Gastroenterol . 2013;19:5598–5606. doi:10.3748/wjg.v19.i34.5598 24039351
   PubMed Web of Science ®Google Scholar
• Bronner C , Fuhrmann G , Chedin FL , Macaluso M , Dhe-Paganon S . UHRF1 links the histone code and DNA methylation to ensure faithful epigenetic memory inheritance. Genet Epigenet . 2010;2009:29–36.21643543
   PubMedGoogle Scholar
• Nishiyama A , Yamaguchi L , Sharif J , et al. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature . 2013;502:249–253. doi:10.1038/nature12488 24013172
   PubMed Web of Science ®Google Scholar
• Sharif J , Koseki H . Recruitment of Dnmt1 roles of the SRA protein Np95 (Uhrf1) and other factors. Prog Mol Biol Transl Sci . 2011;101:289–310.21507355
   PubMed Web of Science ®Google Scholar
• Lorenzato M , Caudroy S , Bronner C , et al. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol . 2005;36:1101–1107. doi:10.1016/j.humpath.2005.07.016 16226110
   PubMed Web of Science ®Google Scholar
• Zhang H , Liu H , Chen Y , et al. A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice. Nat Commun . 2016;7:10201. doi:10.1038/ncomms10201 26727879
   PubMed Web of Science ®Google Scholar
• Zhang Q , Qiao L , Wang X , Ding C , Chen JJ . UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells. Cell Cycle . 2018;17:300–308. doi:10.1080/15384101.2017.1403686 29157076
   PubMed Web of Science ®Google Scholar
• Beck A , Trippel F , Wagner A , et al. Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma. Clin Epigenetics . 2018;10:27. doi:10.1186/s13148-018-0462-7 29507645
   PubMed Web of Science ®Google Scholar
• Unoki M , Daigo Y , Koinuma J , Tsuchiya E , Hamamoto R , Nakamura Y . UHRF1 is a novel diagnostic marker of lung cancer. Br J Cancer . 2010;103:217–222. doi:10.1038/sj.bjc.6605717 20517312
   PubMed Web of Science ®Google Scholar
• Unoki M , Kelly JD , Neal DE , Ponder BA , Nakamura Y , Hamamoto R . UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer . 2009;101:98–105. doi:10.1038/sj.bjc.6605123 19491893
   PubMed Web of Science ®Google Scholar
• Nakamura K , Baba Y , Kosumi K , et al. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma. Oncotarget . 2016;7:57821–57831. doi:10.18632/oncotarget.11067 27507047
   PubMedGoogle Scholar
• Ye J , Zhang Y , Liang W , Huang J , Wang L , Zhong X . UHRF1 is an independent prognostic factor and a potential therapeutic target of esophageal squamous cell carcinoma. J Cancer . 2017;8:4027–4039. doi:10.7150/jca.21256 29187878
   PubMed Web of Science ®Google Scholar
• Fang L , Shanqu L , Ping G , et al. Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo. Cancer Chemother Pharmacol . 2012;69:1079–1087. doi:10.1007/s00280-011-1801-y 22205202
   PubMed Web of Science ®Google Scholar
• Li XL , Meng QH , Fan SJ . Adenovirus-mediated expression of UHRF1 reduces the radiosensitivity of cervical cancer HeLa cells to gamma-irradiation. Acta Pharmacol Sin . 2009;30:458–466. doi:10.1038/aps.2009.18 19270723
   PubMed Web of Science ®Google Scholar
• Schulz A , Meyer F , Dubrovska A . Cancer stem cells and radioresistance: DNA repair and beyond. Cancers (Basel) . 2019;11:862. doi:10.3390/cancers11060862
   PubMed Web of Science ®Google Scholar
• Muto M , Kanari Y , Kubo E , et al. Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J Biol Chem . 2002;277:34549–34555. doi:10.1074/jbc.M205189200 12084726
   PubMed Web of Science ®Google Scholar
• Xie Z , Koyama T , Suzuki J , et al. Coronary reperfusion following ischemia: different expression of bcl-2 and bax proteins, and cardiomyocyte apoptosis. Jpn Heart J . 2001;42:759–770. doi:10.1536/jhj.42.759 11933925
   PubMedGoogle Scholar
• Atkinson EA , Barry M , Darmon AJ , et al. Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B. J Biol Chem . 1998;273:21261–21266. doi:10.1074/jbc.273.33.21261 9694885
   PubMed Web of Science ®Google Scholar
• Engelman JA . Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer . 2009;9:550–562. doi:10.1038/nrc2664 19629070
   PubMed Web of Science ®Google Scholar
• Maity A , Bernhard EJ . Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy. Cancer Res . 2010;70:2141–2145. doi:10.1158/0008-5472.CAN-09-3615 20179191
   PubMed Web of Science ®Google Scholar
• Chang L , Graham PH , Hao J , et al. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways. Cell Death Dis . 2014;5:e1437. doi:10.1038/cddis.2014.415 25275598
   PubMed Web of Science ®Google Scholar
• Wang W , Li Q , Liu T , Chen L . Dual phosphoinositide 3-kinase/Mammalian target of rapamycin inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma. Am Assoc Cancer Res . 2014;74:3951.
   Google Scholar
• Cui Y , Chen X , Zhang J , et al. Uhrf1 controls iNKT cell survival and differentiation through the Akt-mTOR axis. Cell Rep . 2016;15:256–263. doi:10.1016/j.celrep.2016.03.016 27050515
   PubMed Web of Science ®Google Scholar
• Shi X , Han L , Sun T , et al. Silencing UHRF1 enhances cell autophagy to prevent articular chondrocytes from apoptosis in osteoarthritis through PI3K/AKT/mTOR signaling pathway. Biochem Biophys Res Commun . 2020;529:1018–1024. doi:10.1016/j.bbrc.2020.06.032 32819559
   PubMed Web of Science ®Google Scholar
• Alhosin M , Omran Z , Zamzami MA , et al. Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer. J Exp Clin Cancer Res . 2016;35:174. doi:10.1186/s13046-016-0453-5 27839516
   PubMed Web of Science ®Google Scholar
• Sidhu H , Capalash N . UHRF1: the key regulator of epigenetics and molecular target for cancer therapeutics. Tumour Biol . 2017;39:1010428317692205. doi:10.1177/1010428317692205 28218043
   PubMedGoogle Scholar
• Jin W , Chen L , Chen Y , et al. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat . 2010;123:359–373. doi:10.1007/s10549-009-0652-2 19943104
   PubMed Web of Science ®Google Scholar
• Daskalos A , Oleksiewicz U , Filia A , et al. UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer . 2011;117:1027–1037. doi:10.1002/cncr.25531 21351083
   PubMed Web of Science ®Google Scholar